{_hϣ@dH@jX3.:mu!KL/T6,u{i3UA68߼v,ϱFbkM};w:5{z#~lU*vg*~VUsl[Vujnu-;hl[s6IkξLEs[L?;83ʶexCNP{;.5GZz- 𿴽uN~.+S-{lrݽ<:]'ҽ\?N-dRoL&-k%Nw sOGFlo#y|2:|aOQ-ld<Ŋh)G7[|y䍔)xck;xgyݛ7RcP7$ɿS~k䭞ZѰe?DRQ.>OOƒ$#m^lm^iA$羯w2 Z~0P/nYw(*W3l3g%ݳ-Lߎ 4_^rzB/\oo Igd0{!G?銢^ڧg+Z JOӤqi/:YN ^]Nn+­~|xuk_:_wl_^pcm?iZ'#o7,_]߻?$FF:p`O)37w]özA>9cI7c?W2HXl_GΥ<)XGr,KP;#*^|RY+@TnN9.l?rá<5>D)Osʡ߼iOwOs ߔ-iFWǧc#0}S_`ɽA<|,|͏ɄP ofiq/4᭾8%׏U:=+3}P-pj-m4oӷ s'N#)'z?rM3Z7 ދJ~q'gmQ|ar髜?se[]{JpQ{w|yo+kIEQ E.8P/{|Tvn'd𥞬x?G"r"fɵ/ z~)ɋ+-?R]W~Pm'D"N]:/5۹>OGc{qGað{苛󟰟gDkg{c[Xm"9>'u{{'guF֚]gؿL[cAU+*r<|g9ʩGJ2:uo 3~vwvU83P5\_ޫkG'k|q;Q {t|.`oϓG`dWWHgܶ}x./:{в/o_xxܡe_wvu/:]>po(ןsW{ 6`J'G~AbOQœ0v >W?tG{_Op;8Keݿq|'mHԓߋ'#UMOdA?\;WGsMVzO=ZgO^_WN tp:.mw] y[msL}{=׹'kOtKzTՉb:щ_F_ ըkWѺ8? n}?͘^Xۅ^z6)9tdXF?ipxعZaWOViLks߇๵ǛS\N&OEl\>e ~ziK؞Fl$ǧ~,GM83Et0{;->iムK [oÇw.ڻwvghk9o6?fܚ]?\u'0~Ӗ_OO asBWr&4j$8Γנ?O_o?t6&?]5Nju^*ןW{u<`9gG ezqZ48@ xpNt_m?{LݚGPߤKnP[W b?O:4󉿯\O?1L;9_x(;ǻȓo?zGrzv[KZ帆jX-1Cd>yɓ&?eoB'>Tly84N00n0B.LCgMh/,?WOɾ>[L[E#cxl|P7٠yJX98==_=xf$;Vԙ GĿuٓGP[N[_>ߴc򿉥׉}ipmqݩ~O'WJ8|z|Ӥ:8e3metfc{! 9m G=p۽odro7~N&`G??L<4v^cW Г]? ӳYOʕ{Fet:˂<󢳏 :i14>)޿ܕ]yLӃqb29Y6?l+?͵x9>W3Òv1>^ϬI+=̾\_Ǖg{z[phxz~/Ó7.GOSiʸ)(`M>nvxhQغ|z8tLÃxO?f+s!fO=ο^)ExIp6LԨ2/&GƸV籓&mdgf>xUqcQl9I9yē§>ǥaƍIX\щuzh vIlc˸br\*t7&zbxb\h?v/z^~)Ę{ܚ6<9ܶz2`x:-[5%d_|)?D3t>:Ҷb"fkyK[OQ+I2aY&/5~u%ic.~x?VP|3YWANVތ[16ͻ㸎ӛo闯>l-p|]uRɻ>l?m|yw%o\Y|Ƶoݼo OA_4_<4ۯO?iF3w?ɉt7_ˠ[2wi$~{W? $ZnwNvɩduj?yaTpyGQɶ"{,4qM3KNFNjv;G Z+gq`~}ef54_}%iPæ-=զ!}ί=T$]V/>Dzw5Mۇg̾wzq_v;-wm[a^bzcę~;;On-،k}*7otjrߓ uӓ9jKMOg *AF~dz縕d\oƒ&m(/2''u:{q|+ʤ汽rx@ihv5~_b.U~ٴ 8 &W˷y:wir?9t=45,<xh^lCm_;ǴcZ9nf2=J/0g龎W=:U~Jt[H$'i{|8øO>m7\OxB̰gmZg:xkҟ/O.ε=a=;3_Eml4n6j4h{`LՇ9qn:s L ^x}uzobƗ'ǃ/0?iO9mMN^/U4N&,"?_qbpѿ1Y|\Gwq⿅dw?R?X2<$x_(\<۽ȏGe.&5IIvi:)N 7́E_ 6/{npwpv7o62qIn?b 9~<.WgZX>3emq|Oneg{C;(Dmxv#yx|1J]]o%ro J|1\ϴ.>ϝo/;kGvB]*N^yCYe.'Me2wݩuKqs+q|<w˃^y^κ{ڷs<\i] q]\U6ڕA{|[hlOלT`zֵfPR睂{pN Þ}u+V* o/蓪#y*p/*Ƨ-R]QOgKZYVbEԗsk> ydl9vQl=LΕ:?定_>fݳQ?_쯽?-\M|~v)fޱWR)6.<;.ivjױZ"Q<Ȩgno6ow6n RUϲW[qwŋo/?,|vKljv{`][ji^Jcpd/γJOoۍ7۞جfWV}qh(oOvrԹݻ,UFp^i o_85 sԽQr7 ^dI,ծLk 󋻍o/S‹XP^X9;(ۧ}\+XM/r޶r]沅ԮsQ+A=uVxj%}'1iPǸ=U:ڠ2Jެ]߷]˶rq/2w_o/7rz)wgkʗ]+wÞnK7ǥ~AQbxQ:7ߊ_>jW_r| uvlnwGJmSmЬ`?9n;.f7ٗĶv}>흺6^)oX=.8T[+]֙}vֶ_t޻^Ώ_2-s evq[?`3'mΏܜ-&3#м(tFFa)JNXw.-SZj_gVu5;qoZq|nz{|>kۻ0ں;{QΝFe9/ϜW2k盩OwǾ2χ{ȸM~:# H2Ķ]KϾg~aAVՎO/ ~J\ovmsB<ߟxslSmxw{V_(M"Wv]Uɦ[W.sy}˫~joPfKZp$uJo[GG_\>e[m9>s~Taso;̦NRi'?=vt63J<7Zhb4RsgwݩP.j66/Jg[gS|{_.݃QNou(K_>oTp+k7wZK]SԚtӧұ޽8[>jUK`k?~xv>^*_ޜ)W•rzzsM4ʵ\ihvt?R;+ǟ^>m}LE\p=|xY~t}v_ToXt޼IlG )RacV|sv{{-9\Yi^ܛй\ᄐh[o/ًy\Y+]fNny˿7Ӿmڣ㏟snn ݹr߻LZƵѴ`QˌrVMFl?r}HY6\/vM{ł|hgӖ8es{ّׅ5t{v;r&];{~at۽}Vz;>n6M6:ko.sVvQ۾ΞR;+?;bRWtYwNjg/5J{֕SK%?RZiͩ Wg⦺g^m?MÖɥ>mׅAxƱ;nQdK/Υ]`P;s٭doA}q.s۝̛/c_,}=>5oհpZ*_Fh]KS]̼xq6:IZa\\A'[cq:~NѼ{ocGJu&υF~]VQJ(]5m4]nO??_:OsvM-t͖*lv/~ܦT1j~ّt}Tlגd,_},_r~~ 9wgo&_J_W4%є>*ͽVSlk~R<ԷGp=znޝ=}^Լ:pIƛGѩvpռN^lo,|VӲ6QMčఘ*wgOË~ŕwV8-$p !bRžA(]M]w>Ķt6JE`(ފ㳭 C&+Zl=+GoپH׏{c˵Vrg@((/;Ծ7ūAy~v\s뷛ʛg/AcΆqWP!^$LIfb8=ԧUvaͿAWǓB7.ǽ1=+`#&@KFAa: 13`0!Гf]O2O Iiø|}_ߍ &m:`\|r<.66uvǏgtm0 F0fDMO?dݏ{?X[\qLJϵ| j>?s?twp:~PAX,̤2<}tj(\0Ό뜉g scKM xiCם׉_hG||2 fVLnDM|Bs3LnY_$ZA2sy6;^A kS[ڇ1Ҥ&k3aXq;dcW< Í9]q_#}Q0$[zpUټa%wW3= 8o+#5?i"^xK}*hgrz'ؙD܇3aö8?8=9m;6H-}i[?|ubg_~~/u&N_?~!sm86\ȵg$ǡ)#q?y¿>3/+LNgT{XsϚMiKU{{4E/ǷO[o'W<\ ]|ɕkz*rg^n7  {쟁Iǭr:~P2>0xSvHw–Ĩ%3}xh2 L{~?Afʝ:?)s)?vZEM& O2Z6f{fMŹ Lh\<8֦Q>?$Hn[ӂ$5A<7$qMt6Wayf")Xgs'~Ny4r||taϋ2?GdO{;x8\V;ǯ艙O̩Oh[y-{r6w57clHΓQatz{x m&y8x|xʊSƧ|f|0]\gPʺ}6̇c!Ӎ֧ibSJzxy 3xAm7t/׉?-93f}s箙BCDϦ1YMwdÑ,J'vVS|l䟚+r_̠aRx?E?7;? ;otz?!M?ךj}a?$-d& Ǔ'X|_=`wU[9&AU]n9~799yC1hR Ň7n3oWk?(Xst yY{H=vw6<0v^Sǟf^RiǗOoMݨ/ͫ?Kon?GJ<n[_j!K2xzsstH?^%],$o//_/\WhO.7®IW{zL/u_G >(xGs?x+goU*?nF.?T"3x{Z?nzw[W7GzԿbO쬯 T!Q{zNCo jWhٖy_ڥzG1&wl'6lNѵf5kfQI郗8lYL.f'2"5b̖'%,R?yr,z*u\(ic4+jZU-u%q#t%eJ1ӳ\*H/^CJRZQu^^wfğg`% le0[zYXnD1n9G^"XM,г iFV7ҍ[.='cɪjܰN&gkNq-;>(A~30{SWt* *Rwbq, K' DT)UJX<reVh!Ѯ-?Ur ,FV1w-QvJ7{tiQxH\77W)#w/'ǟ>{q3 DsdXD'Z閗d--'C/Ņ@;Diąb*F@9'BV"L>J)Q$@X"i9?.! X +bx_/SsJVOS .zad3rb2jB,I&?V,H-XXhJi! L7-/VAj ,|t6/Kj^,Q!(WfZ7rrMO+:%2;$%33dsi[V6TJwZi~4@tUEWUH [6 =ZI3TQdEjrR)-"+ctei s2 (ɴѰLLrc7B4 )r7`X00ok-WUn d3r(,\ʊb!H1"a:7DhD -45;;Mxf"A~IT?8N1TvI.$l^s܎0{۔n T^K݇LrbqamA'B/ѰVdXVҽ" k_!ɒF?D ҖV-j!P @ 憾Eaj*^jiϩy̾ Xjš$Rm(H+SB@%݁Х|ƫ2bb[[qG%/0[ljZyѰG4(cZ (o@V3-J\Aْrn[lmŭT՞kHyFca4KG4'װJk7L/My:M`Eu5DOko 1 `%ZM;9'Aʋ¸D!Grjz'IU JY KH^ &|4\l5w5*A Aͷ+v4GdEjrRY㯉DclZ\FJ|UkSQ,(Ѷo~1Es)D[\ geh W _1I#@:GRzY b1vb@,eeRZ\짺kCJMu2"hFs!fqa~)/ ;YY2I zEꃚ\TAN ^ bWK{NMͫfYE1>֛ooۺJY +s!{Mp:vFךT9-.%J=[=6H G׺J(6?켷QjnM1 {!c>:DifK/Eω̯~d|_R7x_>S M!ڐSUjsڊzoiMלJ[EIkU@8eɜdŦ0f@1 nmXۡc٠ߵn;F=)TTqRhEpaʺa80%Śr@+_ s)q@F#bV6?j8+E%uDž|JApBW t麺MxKm`il-\Sŷta#c"}ى/@Ť>ֵF^-Ujh'#?nу 0$xaɩŘ` lHV3"dzҺ~9=UvaGp1.Dh_+if^zi8 'U$.ϋ Ah}A,0h@^OlIT*-x d QX5 @>-e{F(_uDЍd;ߛ| %|I%Ůtcuz Vt?p6\|l!k!vD#j紃G KWRR?yV3Ufs^VzztCcC@4 z A xɜG0 \kHAMXHr"ma,^ibw1rtT%*=bWK{NMͫfE/OiY&\k-1ITnGӊ\Υ:h@HI QĔP ldt0p.DeNI@+@L(20;ng=.7ӺٚS"5!6&?z0-`V[/ӏcL&.eM3yO²(̯ua=PLU ҆$':7jūRJX zhy.uݷzY覤 Hd l" Ridxs:cлrQ,"g}6'VzT*RDyaVzwg`$U^73Hfgh+F8(d+ى{N3W7Runu 1p:Sh5:iE{*DkBVr/9L/՘1+Eꃚ\TAʉBsV)5, _a.D5\]$=XWVt!kB,SA:cW겐(kWUbsi,f.^+9)檙'me&@$+,C@+Me$tGp W' =CE kHcvYqjs X ٱj6am4An.k^lϴZBbPHf*1NvF*LNJ(b {mĂ1 V$&ى'VzT*RLxfC偐x MIlM4ṕ3Xh B0H@jj;kj*jnb̦xns')%%IݶkY@ѭ"k< 2FZoT:m\A~R@oltSQ1z @PB63k4 pf9SJ bd&ulezY *"q/Xdc'xzo;# @\ V̸{͉qABv˟ߎ~m+30"猸:,ʥJ+W+ɇQ8$/ ܈XTnڍn NT2Xx Ck:aI&X ݆io2lj# LI8-grf=]'@vX #`%5YL.f&Zf ,1l{2KȪ+yQJH"  ]=||HlZIm1 "cZTnڍn ?[O ! !meӋVKH }cr_ č1p:ShWfe't~8vZ],eEmny fݒGQ<һ SjFCXFgXͤ3M8i@"Vc-uCKj|tTV+l/vN@"4X0ij^:ռ(ƇEmb 5G/_S2fYnT,TtaM֜0A"Y (if^zB.-.MeD!K&vdYq\{{NlL`U~[$?p*µCנߵn;F=)TTa-:vFךTՄ" $F cD'q]J ̞ݴJ}k9f&اE'u9nhtX `&띜Ō[l/H1 `ܸ-\!X Qԭ 0NjWo󽎕US"(@lw)*.4VC1 "N"hh˶RiGgF-$f>*eޙ}ĕbEV8 7ءk/ DhD p-7lQB4=!h&6C c!Iu\ױR4@JV3[mr@@ȍMdEjrR\^jə?]qB/κZZ5D$"iql^]f)w{9k'/IUxzMpzɎ dqawqWZLwNoB&V7<9-[lekril-AN Yr*B7guszsmX]]vfD!QtRSVFGdJ *!?%+UŸUj7 =;Mpܭp&G0wiJiMnT;%i[rMYZ ++2"h5'p?mz%LE, k3dt=2< |`UkWClGmk Imifw}wN=-rYo^H4i[3؟T!V F.MSWT6I,yX+K|8c󿖖ɉgG b!{(d3ryJa@gˇ]`oI`E;uF@ёh9\Ž)yZZHjNcaѽâLA p$ə@%d6U 2"5b~1"-ZjXC rjVmvf.Hnv#0Ɛ5Y$ybIֿm(XzYWG.#¤{%' ILAZhH/uI%)KA-朑=K$DA`XFU-Hȩ呈DvV{K'O~6yMɕŜyS+4Dr{@ @rbDly9p~jE!XgEm< ZXl?% [>*.]*+ V"XxceѮ'GHm8 h׷ҦYG:Զ6V2X ia,a?A]bqJhZ:޳*:AސąLE=^ V,-H*} BC04R(|%g jAka6Ur"k|@)NC \lVC`'OJNds @JLg+)@Z9jV)?[zsyf\(yb5k%^WxI3, "㡁 BZR72913eyC/y#B,1hwjjèTMAHAMX Pjiϩy̾ KQ#T@vZe!XR&s%ed <3v Y5!g&VMp=d(@$Aِ3!๫:Rv#OU`\[NڐAxm)iI7V:* fa(ϯQSfT;5DTj IV9) h?R2ٮb b!ѽm7WdB.v)Vv;ߦwW7.b]l$0\"c3=yMZO \k֩3֬rͬ&3. b!J\ߪ&띜Ō ˲X (`%wA~=U]+]н>wO_Rpjkp;;)dET$Q)<3GN+^UszSi굛v!6y ;BKoz|5YRr;r:3t!]oWr.(}m cRYQ(if^z,EAC}Bٖ@*`n#DBYΈB8mٕYM, L@APCk: cLBxVcD%, dr5-7_o f@irR`eZJ p zfrڍ']7亮[ѓߔjiP츝q lHqf_3ɲ)@$B4=St9xgg{!afYjzg?gI ȋѴ[b,YVUd_I>U`5%zZf$TQ$i:ibǽ&띜ŌU@來R:M4^Q!Sy&A@MH0cVtoQ=m9F|{< z6Ckؓ& DT9gŦҞSS󪡙}ANF)DQ\Mˍ׃]X`H9~YmiS+݊"@ BV>[үn#@ZyKvx@ lvEqZB %ЫC7VUkj7)"]XbJU|մ5@ŧՙDu]5A+K!$z7~Rn˥~Er:vFךT9fe'iE$K&X;BKp=lU(@UthAaQ>K*sBMp'yAXû3ndƶeSk=zZi8ZSrzɳVsKmh!6=Zsjj^54/(,NIŅI޴(tL= 5s5(6@kh&tU*{mol>JFq^Wř V$ _CI6ѽӚ 1ac'B;iT}d3 Bѳɐ#qfkBkat:H*䮜*iYϦŅGfXhᚩnf,"%j)jy riZZ$uIUk*~ +%@R+0="hP >As?@l)۸NoH tZ@$":J Ŏ`\=[$F@ \"mE·@Ȃl BVZjGV*fmϊ;k[-Gely#.QB6d*#Dubbd(JԩFE66(T䊥 ry>,e$JX@f'cXNC,p-TfCwԈK:<9 j*X@ئ9F&)EK/v{Լjhf߿1;LO%i@Ȯw`]6n8@qtqt]K\a5d_XEM;9'A)⫸e6R=9A_.ƴ<f~P"˩\%Ax]Qj [ѳC zө-4)m% Tt@qBSmgtYMYM՜(̴1#[B\Ք7rb<4X/K=AΦΕT/jFS~k;;qCk:~qp\@D(z$Yٔ29RD};h+n^C7x|yj/m 4ؐ`?ѷєv=wf҂.tV;{xJ֫Ta&:A!pkr^˖oLVT(WQWD'mS*]7nE`H XMFnR)˰UL"(j孥pZ]Bp{okTZ^\VRs_kKSQ+Wә+1]Wć?~9>֩3֬rͬ&H z \AFQ&W,Us~@lqlkǐpjR'wK)f d%eR=Qdaa̠OkhڵADiFYQd}^ tx/z'gv1#JS! h`ᢡYI3둲_/:vZ|o rIt)!{X@r5[fGsvUՊ Qt"a%'Q\o^_8mhc*Xipa"DS[ia{L%V3WgL<Qm"0nW O}ta;:DS Cf*@m ^y#ՓA[ʍz-[q3zۣ#K3x#=%+U XgձMC'N0n7wkD DOF3P%aq0^z<;X@T n{bD0= hJ-@tMo{R6ݹy!ae{rl 5\ƅ{{C zf DhAG!B@>`5Nѵf5kf5AV0(T䊥 rNZΡ`KƢ\d~/2 O 1^b!vǼF GN8@,̀)(UŌvEn;UFWHnO5ˊG2d?ӈ kzY r>/.t$ "h; \dG b[`5wjUoǛz<=^Zhftu/'j[r "ݴnXUpan @7yLm8?`;qAQf:%kb._өxIt zHl9~1bWK{NMͫf [bf5YL.fLE"TT]kVSfV̴* @k;:d],~hJi-"*[PjZ-ov&}+ ^eP圊zZ?'˅YmsUv{;ؐB4BdEa@IbaT93>Y(}x~k]{^-UrٳMtӓ.~Yl9^vnzv,ty/ݗъzGoyKJ( "V8jEMF'eWDWAΊV 0R<;JXI2mjHzRUDfa<3 X4DP bWK{NMͫftJ Y;0 {mUⱘiY'A*!B^Ř%@؄z}PANs:+?ią5+RR6 z7(ƇAo}z@EVBK+x'2WDWM;9'̳[@DZ bF5%`%Fj4:-: X"ayV5yW˖XC"YğB WFiR͊?@ȝ5ד: &HŘ& \JO("# A Eꃚ\qZ~#0Koia&% 3Kr0,3ZZ5ڸ0!8:zeY+b+cHXĠ4nmwaFF\ mmſu;sVYwkqU-e~'+ZL@1 hwiޙ2Nߑvђfex缋BKCs3F߇^-95568@%UKVnq>@h+jAFULV:]ܴdjeY9!9k1;cj-B9}kH(DaֈZLN/Da),5{mU,_Nu{ Tߎn-njX1P$JXY EݫPpE X)p߽7UF/g_~ݾn.nߒbň{M׽eӯTVB*|C;rJ2% PDG^^,i 4vDFzOxջV:77!py吷Wި+xtjF~AI00K/S^,dMtIqZ˒BBzFi ("ޝx3MI:0.([wIV o0୵O7wM]mBmLE{:vݔ߱=x``ۤo7ow>y`O60ųY vSgxU5Tѵx ~nJpm`+j:@n<$BD`, |;Nl+l4ZmEX.oǍڢ4tٷ[>ik6"J9Ƈ@n/d1 pESX7G6`WZl< BO(||sq/֫4.>>[.T*'r|0"RCOug5 @e:>)9瀼GwGol#=.l aP97~R?_tnZcR{Q0D@%rA6;a%WroBO[ vqKiӹH@Ftˋ(˗b}<\̒y|0Nd"-U,E籦B+YOJu ur6ZY%NbV/';A= 96upZy< Ep87Ȫs/z9o{O0O-fI#K'^g%WAՔ,PDAo&[<: o%MLkQoDl6Z@Kd$ `q4WV4Z011|RŮhܞrJNeBn~zYbQ"pە{bO 9G:/Ers;7NWW]w;ͮgAexe1Gٴ %HETuj:Kgӭx雲q|<7~R?_tFkz3 vpKv7id댢vW bhA*ك-jx7k7bC=28ot128#%rLz\ #+q%am4ڵDWOEV08*dkxHǤD|ݔni5yFPDEϟ?<~Wr'@ѽUxCtqGZaxpSJg޻ɃաK8 :x_BNuxZo KqxR,=H,x|7ݵ@Gr8R`r,@M6u3fjw֊Fog`ׯ8ʳrZٽw+N#>_aܟo@nu "a#f]b?WcA/]Pow%(Syz 8R<[fWjX]ue0Zi2N[IeF.= w??0: esOf^my~8[۝!T h7'i%mߟm:|VۢP-Gi]Y%r&,tzQ\f3 nkat h`, xsg2KNۏka9Z+m;jٯw.i O +| s1(w֋ pB˧Vw74Cy8|ݨ(= ZQ2Z6)]5*t|wArȗkk٧WZ- &xMn?u4௯W_K߿ZUه/?tP@anx7GeV AKsyW @] p(B_j&@EYehӟLwݶ 2șz7EAվn.JuvSƂܟC1|y~*Wujs(itJwaw7NWW]w;ͮg/\<{@nM)gP8Y:{dЛҨ. k=2zNc8]4Ywۅ@AQҿvh3ۋ\l}|?|oǸs$&d3^7h6vg;+- l#U櫫~|;׃VXvpsrvk_˥v* Fn|~ITjfqW8Ǜnr`WpX]kZ̳nh '^ 5,acղׂPza *v:9N3^6:gI+EkێgeW_66ۤ}\6wgnOj. w o31(P/H_cժ۾n.sT@>QPt\( _q*rIֺڈˤmGlz> :,]wWnIEUnѽT(tх{")U,8jKX7S_AЕQҿvͰA/R#Js mt6uP@f6B#7R5-^͢_u(z_n/d1 ȗ\gx\I~(שGlfN/ *rIֺڄ gץ/˟<ޖWYtL}Jd\}ٷWA;QP@iӹj_RY/-ӊ;IO@s12Ǜnr͠kA>f%`BޮKxgqlW./֭vneIRQҿvOnɕyvǂz_@] A74&zEB ;o%Զ^yaNV2a~x5놼]ʕm{X4qtwSy-Yju{\ _EZA_{!RN#ʿ-Gi]Iɠ O}_+k!w#=H Vt]U4QҿvrPH ZktZ 8?O?lhtܟѿP3}s:;iew7x .r6t}sm U->8)/>bh8`Oh?j,ӋIkxj.YppԨ/nEp_Pv< 7wșG1谞a{|i"YYAή+r߮kmz~R;Oj?$X_4z%7<:ӹGnK/_WqDd<ҏᤜ|5Z8-9(d;6u}H{7'*]5m㫯|_N*do\.Noz}w%~J ~UÒݼBG3CCSNL(Ysw@n$0oUM/͚Sș.ۃf=|Ql 8m6Z{mYق-@<ofO|Նf>{9n#tGn{;#v y%h:}q-jd&ڜLgOպkq8pz>xsI jҺ/gge;Ae:e4oWrv]LlS_ao9]갵w; C8[s [ *KBJ>-:?+ pOߚ oB(,]F՛$ a|׿~-&ap!Wlv?jDZֹ`8Y4tuFQr4U oNOUO"T1h<]=*ƣd?5cig PDw (T4[\yaƷ_?Kg_]˛ c(qFgӸ\Ynfj^.A+vܨ-I#OǛ}Y/dv=|VnB(g> e,brL kS1#fnl\Zя<=b{\/˫eQiGOʳ7nƫU*i}-vz}z/mϟom']NuH7 `@>JQc1^LZóUw1)1'pֺ˽(>YuQgkU8iӃ0d'jw/-7{r2* eMWt-O'xMn?uC:a)@=l q|ݼTr<{1,_d'&<iItzyaݍʐgZ v";XJ\Uǻbvq=}W?_}Ͽ拯rRٷzz:8(O'Gq;kE] CG% u$ \]}%]\ݞ-]Djh|^6M﷭`sz9Xfb~ЏvKa /[ E~((|;Nl@Thn  !O$ՆG2~Ȯ > 7"P:7kUW ,.|Y~W'rG|zU΢b] xK՛ S3Mh`\nc&:+Z+jmTٵ.Gf,@!iySy{[U {7>_pgFD7",Y2_xt7ҙ(K%5+4Tvh4}|*O'Gq;kEAw,Ž'AQ6 +v.4.W6񮵛^d[AFmHQ}:ۭzQzhI| A̒]eu闭vIpdTN!c(1u: 7m1oJ/S^-tijBޒG pc0x^ GO<[fW7vԐRI=cG |ivPD(xVƣd}ݮ]'E'hv#ɦcay+zu<ߺkq|!H\z. wNOxYhu2]i\ɪ GޣelMc*f:Z]7WW_K߿Z@!x\P_.I'%#m )DIbX^3R_TEH~ٵQ9ϲZ7\'VL,J*c?<)݈ +b"4TaX^Uf')'Gq;kE?v8y FO4tuFQr4ap^$brA:v画ePbyU]ԚhA*I_uY?,?dOit'o)=+vb?/:A_j$oޛIE$ wѫ|2FOS٧z& 2N( lXVp{S _7vLc( i}}vJ 0ooS 9{vU L فIA(d$O>b:\ùpv7id댢*hJ oץ/Y<[N,.`1ǃ,r]-T_}bױFR2oeul $'×j!gOTh՝W/hxTwGݨTj68_Ԗ{?ZH/[ J.h͈s"E8Rei}cW8@zϯEƻhvyp9\'~f0<)otxlz& ZժD_Re3wUmb5vv`-8`1_e< k]Br,zp8΃ۃd08lfݞ]#[!'%]pU?QP@oul=P@Y] {^ g7B) p0 b0х^␿4\ _o.eފ7w#cxt|% ģlS[`Ty2ExA*@]vr3a|ݯFojÛ Qurf5+ - 4'cMW|(d$vb?/:A{XdB _(_ kk!gNO 8ε|7ۏc?&ypi5fnl\ZQЬ1})!nE| ?̲4<9°|]2(RɅ, j#?զUmObO@4tuFQr40߼?!|ݻnv;j۵(GƗ$@ON!gz&|s,U SP@%ݒ(M"ZoZ~Hɪh%b'7x0~[*4z{|Qu@XCnJJ4˫$":ƣdNj; ˿/U՗//. _~hy? & B!oɨȸ.hZNxM0Kft*<;U9r P8:r9ӌ8R2WjN2mgt7>%(˗ ʲ8-:Φqy0yɱ@8[sq|M^?)oJ7J ȗ;pojo^(v]*Buzoj\VfGyV4g*NhI#K'^g%W?])b7IMi\d^^ 8;(`q4WV{9h0]K($}I]x̵s 4n!u _0[rW Óߔbgi2(/e@gxdxgq9]'+?Y,Q)ySPDɪ]4];#u oץ4\$g2!<Z?ߎ*vɩ24ZYUmة^lԾA%ƋUuQkv O!E,p$#I#K'^g%WAU E 8b G1|9xlx݌ٸڝUkd##ǵo۵~^# Ȟ0w% r,$ ǘ;2 8Re}][ި_K ٧.NS#vPDqOBP<1ÐA/]ЪuƒM-K{/}UtqMdWx4Qq4gj_u\ G"Q#]5vu(0%xI#K'^g%WA֕y. ^U՗//G1 Qp? Ghp 揄j(gNL"xzaU'/~7n <$ 3< %})ϸ)*W&>kt+*Ӈêrqg0;}W/mϟomQ:\nN:5;ț9 @&xMn?u4;S cKU\Mi$DڰSL٨}5ݍ֯ܺ'OW(@K/_Hx*?iQ|r2ƃlXEgӸDlno.Q= p$[r6Oy{Ɨ<.x,JJ5䯒ɾmMWIiHh0W0ٌ8Y+ ZOU/P|IF@~ު/7=z[1_b%u< P :U4Ѡ٘ pr4tuFQrݷ+Cޒ,~-sxVcAlfFMZ^޷5++F]Ov'(Y3PyӿynHy+Jri.Ƒx@;gS?)C@,O\l18RL VoeY?ھQ}ݮ]'E'-g+]e< QҿvZxx^eT[ݪqݔJ?Gj)^\ΓyY=N.n|!BSMl3M,y۵T_O1Roo/Is>Hs/sR*n&(ΉxTA̒\,.s}7__׫ydWŲ|6] .Q:WT:4L"-U4n.ٮ> ’2$d u @U&Y-z]}R>~˯ٗ|w~by?[@hG>ٌ8Y+ Zƛ#8C]'qlq6@񜖃}ݮ]'E'hv{ap/",?.NY9-< 䇫{ o6 Ogxqpd$QGtQr%TNlnNO;@*e]feo120 $L(om ߄8Jh5WCޮM__.o*x%(?a~q\*iO|{\I[QӍ <)ۥO3[no۵~y ca(qFgӸ\Ynfj^.ǹ(qh$>ofOlOZ"w|Rr9?|7dЉ@_PvEk38;w+8JWY 8tAޒQ98<۪7Iqz\ ׳OQҿvރ͵5pk!|3nJ/S^ͣY2(M\$qh$X1!Hvrru6-eoҿ>]ϢEP d7[/4ZP@?N۟JQͦҋv,WlfKȝy.ENjrZD|&gaip-CKƷCB f4.y=YI1[ qK>7~R?_tVڇ*6vzq7N;^xKB3u 7ސ٧x݌ٸڝm〢`ϧz& Z޻οޭ~T0{ܐ7ܐٰ%NOjipP@ׇE]_Y|dW, _1fO!g7[Nw&Ys8Oռ9>,}ePo4?junCJy2E:[-&ݓلÿ<ݽKǝph2JAh% P@A޴O'H8TbyU]Ԛ|Z~8.țë]Gzy|Ѓm;llkI| zj 9{x1u:?)9|д7n.Q{1ntgeqv֐ʫM|^Oi|K]5j͒V|~9-<Ŕ{H.Fpz1i V:{l7%C^i?B]WB_:L ^%G {r]%8MV7_Γ|OφvQ]t]+с|]Wv}u>n_nN_U|g[>E٭u/ٴo>$#KVf]OOa(8ε9٧o-a0^:0|Q4:awQ]4d3^7h6vg9nڐkMW[K֛5Ͳ+ OJeߐ7}h3ѐV-]l"OJec o.yw?Oյ颐=Jf{bx}^L ,6ڱ<@Ty 'xMn?uӟ#~]~VNVh8K"8hHi#) <{kY7 +{r)#~-lNx׫8y0ٌ8Y+ ZjhPDj R2/aw:-'Uן?7~&,tzQ\N-<{6{'>UWKe@ @܆٪52;șy?Y?XV.(uxQ9J(+<.]>BڠiaMkgt~R*(}(bFjˆ(M 4d$sTn3clfNr [jo\\?jN*W(.vo|ܨRU.Wl1Hd2ȗ GVqT_|ݾn.4{a|ry >pwܞfSGc @VV7x PHqcx~fYF`_ ٵrA}7T;)T}yBOO<]cY5ZUΦͨ[jU1m(;i|p,(x4Ei]Ihd8A^) 3e8@ k Qmv-zN TGq}Wo٦>ٷ6ݫ%p~,]?4x4MFU-@]kPLwKv7id댢*huao۵~υ xQҿv?|?x't|"8v_E$Y gɼNGMAnQ2|;Nlpr3Vmr!rv]ގE#iDxo6E}~GX=|!^BOjǺ<Un/d1 x.IպCSǗ.4i7j9ײa\/j罸q(# {5gPO+(/g_~ݾn.ZG7{kᦶ˸ :-O~~3hua04E#uQ: 𤔌 xdQkw6+@t1up1 J.hu[>PD7/-o?_\LYMY<[N,Qܕ{ݤN3mn' û|% %jfWˤ.Pp6eZۮfM}\/@Hץ1e}эow8rM2u"R5΢q,8b (f K9@!UtlI6> !|}CA\VxJ`xG (^ Q A[9؍%e=yk.rzP r7Ű ZPyo/"T _qcx~fYF`_$U4^-UUaXDFouOj&wV;/?n o?{npS1tUkǃ(-Fٛuˠϓ*, G[vVtQ :QK8@ԩ{uA~%waI)|YYrvhhʨq;gY<(QҿvA q1.a0lfݾڡCW]UNty>i]f":@>|zUBoH:~h S 3ŃI|ciP@iS!g?NJV\n |% yY4Nn;eT8鍓Eo뒬h[L 8,@nv{Q!u$ (7cƋE9lM˃h:EK7Mwwût:}q)%rPY f{zjͅ%>bP," s=8wΛ8sPЮUCW<=5trOEnIEɕ2x?T glkI|ѹs'voR/ xHE Ys$cj08ƇJFb%HV8 *q.]t}VH#^@=._\vp=vЉnMfQP@ײ hHh0aSf}9ZpY=M`GѮ r_:U=l!8ub<.giPݵ{UwFxR];,Wfz/Z礤o@`d]zV>(to>Yad@! ,RA@&{fwomƿ?F4(";'ȼ5ѯsxߵL1~&xMn?uþPOU @nJ?ό *zzLgZ_h 7!JTMVWɸuv>퓤~wRto{r޷MlMo(͒hZqTpB@8[z'/I'@A,i\En5t1kaT+a8+7Why< Ӻy*>@ U3zx@G7ԴGHd$r]d3^7h6vg(h׫ '`MW~|to&s#+W&;AQҿvA q1.a'j;\TW݋}^ F9Zj!/U՗//((| UF|\M р|I%Ei]zOު` !r0A^_hPHޫX,< IT,v4\Ⱦ(S-8ˁn]x*h-Fd]UK2Wpt pg<>(ϟ@|zQYZ 6ыx݌ٸڝlcuq[] W@p,Gty1O GPک)p4dP@2j~*zm5wf7OnIEUЪwÇITZ-h-hOdi0ZY.@qbp1\۫ECR!l~9쪼 4Zq4(MBD×(o z3|!Pqk ^qxq&AH{ʕAkvIf-+]o5E+h0/޾ĒBn›TOIs?bOiӃn^#} xQ9x8p9{yST&׻0x렧8v:恜>l[7z6ܔf,#=X]d5-xx @'C, _7OZx4#UillkI|ѹ]5B>Q\ Px&t=VoVqF2 .jykS?_V-|I2{M7.GI5~Q~ٷ/ٟ??|7斵Eq9(󯻡?mݤN3ۭvv]8HH9)U|^G| _ûn(r@YUyA/:fXzoÒ/|Ò%=wKFX(x]yՋ|6 Ö09AB _D7axR*Q98|kҐOz\= n|0]c(w&aSíM|SD`\mt6oqhnP _BPofO ۽͑S H7BP;~ÑJk 5T9.ޚ$@vSIZy4^ꋋYw637eyy6kGab=mN'_l! |E|eq pL&@8[9^\zݔF Kjۉvٺ?.AXU.|Y%$oi2EZ*e(ϵ?,I=tO}on;l !{!LQj qvk7nJ?5q8-x\WrИ 0"f.OĘ]Tˆ=ϩaۑVk * w @|:ٌ8Y+iEHJ}[7[X P@A _tQ- r9Nv,rݞ/Y{zqy޺2jy%ǐ^ۯP W_M~~3hjaS* $<6ϐy4xf]ONnu]^,r ,.GvI4>2YdJQ[4FT7vk^'ivՕy;x[{'Tܽ_k^"nNzmP즳nN_U|g[>ysڴOzMQH&@1*Gx\WWβ-NI%ku+jfrZ֧?-kux0kE9w՚7i{vcGt*3gy5/ww-ər oo~31 T}zЦ酮3̚~t tA5[@zQ |njԚ%rp5ZY-(]\ݞ-]Djh[{k\6M﷭`rv &G 'FwapPlnB oץU4xz&߼}NrMVu{۵:ߍr =sXD`\mt6x*l4Zm˅s|vܨ-I#OǛ}Y/ڮvs^NJ<n\2Ks|ݿ֫vSzW6Q?Lߖxa9o4ݱ|p PL~mr9odU{> ,m!gp%,N4l*@<7zrQҿv]p|*0vzQMY::(}d(R9gM܏\lhmIxx1 8)a]{N (h~ԶmqvYKdzjk6tSҤ(Um{1wS4$1KflWŸ9[eO8n/g_~݃&Z NE,/}kY{|9(-xx>yn=<)U.G`5l x\rX#2*NWhlkI| ڝfxuַ,"Ax\VM+W+u:ofObW _OJ 5@x)n/d1xܶSs]*ߔ~*J*)d5,acղTΫ޶UI(#_P8zHh{>R\9ky{\QrOHP_4gY+N|kRvb?/:A ݂)>N"y+Ax\ץr2WL _w0lfj P@_@<+Շkn- C w"r2/ۍpd$G8V4tuFQrF!|{ųevuO1O XtkφjiEq2h5:a?WPo4OU ~#EwۍFv/T OB%YW@σTv(_ kݭkb s1'[@䮒h5(S!Z={!x\f]ON6ox&xMn?uy}߼ޯln_|\\֙ch"z*# (àMY::(w }ϯ??bSw??X5܏{*@1'MjWzgo/'[wx?oC*٨fjw.BOgMvPlG:!˯_~ ɪNJd$Qgb8p ]":+g_ܶ=>J$ [=gܶvۙ@ qQ7Y"KN=*ŒJyq(p]g[0Z2Y w;sg4\?g22W;4ūq+^bAUiPMԧOOGJΗ\(﹡1$q<E]efw:* ,(`#ezDhE }:EjN@{l1|CJ;'I*ݕO'HnW*3@OH?m-'1յUΨ[ɹ]CHw  tò+,NSK|jNM 0HH_jm]w3u7UTDg]M aU\jhiGIZh!Bsa&?QqBeZv@ '#}-\ݠ' ۇZ_Ic4qXӨZqU <qQFA5'8K'2lr}[a@Zm J@K2<[^g0.d϶ϟz(eT7eNy{Y^B77yX[D M΢f~o3tۛȖIcE,z3;nhJ,д>mDW hNd%@ѩpA}: ۍ(Gȟ>1oҟ4_;uSc5L;Ÿ{2,FIf՛43ʦ@'Zhk9>fƸpךJ7 %~Lb ̗8V+oQ5lG.kzaf`LֱMaddgdgpTuH$#x,W0i hSnǾQݔQ^d\X!m8^ͣZt]js211W_3.3AjGcT@ $(@dQ:mNtnpf@M{[K(J0 NQ⢌Ƴ@ݽ"\AE :j R;\0Olg<ѝF^=;@/fi,yfҟ4 ѡK;ϙ IJȞJ:-8iY̫SNI2tanN @v,]3U@: uFhѯU:n]M-wi< ]<\@ Q-ga'(]fv.*(q)Kwh>VE:4k ' R25 MT겉XeQN <<7a"1}(^'fNer9ZI2=C@Nxɞvܴ~ĕ! NQ<'UDf*8S7Y%d%lk9>fƸpӵ*R+D K|0xFgc@m<|w. -dJh}Zgf]fnύt$ rfMșh5qRrF ZPhJF8*idW[ws? -TMW5V{Rh(i} %?Ǿѥ;*{5d/̈^o7FN~ .|& 9l=zd㴷MR]tiYvn's2W#\@ӵޓAL+ fIכفp K Z9ƀt̛%}*İ5qog"OjiNk,>G8}rCvu]LGLԄWo퇯>gp @LsC} %~Lb ڙ/gq\VޢHdC /)vd *-%ZѼN NKF@Mr 7n-֖$rKB˂rb۵;+y÷bBD ,GvQT7 M" ׀@dFh|Klѵƪz֙Ys ŚOhz`S/ i:)a"{B2i(%]of5@+%gh!4> Q$;f8vh.Ll-'p Sgݵ֩9d 8:mbM+ H$;4g)<6Iuq9ǝLrl'#L =>n>}m7;uF<ҺkC .R# ,m`B<H7i Kcb%$<0trd{}<4WU$@!,?ap0պwJC h@ pidak_3.3Ak$3EH㍳eXQ0Kk 96:=qMCh!Ʋl?=D0Qݔ9SL NZ^=˼b@קWצN0[薛^aiZ_IcU}H56$%dh(u?@; d{CC9tFn&|@.jy^'ᘦvB˂rb/=8&pw '[rrMOwo5u[{Si#Zzc4,{${I(g ONsQ- @6F'2<7ʫWjXy_uQx Ҙr[q63ƅ+,:i}UHYv }p.qAgpF) FO[¡7 x"\܎11=ӟ/Oha#Y<'~:-t÷;7  љcG Wb)1Zϣ^08mT '#}-\Ӻ_ݎw925&`{.C' @h2ĝ&u#6`del[='٩OZڧk@GQhv߮'۽ۯ}߿?|]>0bO*_z>HOh%wFŠ na/e+ E_3.3Aۻ"hl9Fv:MnG@^ضr&\wo.9\pi7yXP<)bdt0 4 N iΘk9}3vLu104_tCi@+2_65< kؓrylԵ,{Z%Naףը2 յnyѶ͘&H^IPm뙿Ie  6ltiL }AnBq0"pYIj0P8GfDK/Ʒkzڽk Mӈ8NQWfj4Yn{F戻4hgHv˚Z襚-ƊYfv {gVL8g*)6-t( .Mܻ5Lf ]ϻk|i@0HH_ x*2^[p{t^@6n# !8OalynZjdl] M94m ppii8dakk4M}xcۇI@QwݤzgQi.EL g{ߴv +@6&.3qTuU1 x(m"A* [6DLU$y Ʉۺ4WI7jaBXiD,}:,[$\؎rS/ i:)-t1mttE>8 !!O|y9,Wvʍސ<q\@;}]lg5z+[8 A,6FiL }1 `hb7p2i(%]of~?DR (Qݔ9KutҘhtAU]XSy>o3tۛW̬qnk[ڵW VNjk᪗^{x= ȌhpmGγ 3 e.|̾ڸqx t?^0¨T<-‰ZA^Q^?x X\Հ1dO@.RI`:tH N.x:C/MX7ʈhrq -3JgRccuMAB6$JWY,n\ ]ϻk]ti̺ܞFaz*OL+ fIכ+Ľ-5q{ Ib4dhXYIS8dmi@ ]߿^&`ڿ8ɩslK5j< &KNms:.u 4#$\tٴ8^t_JiL }D]63"GB>5P<3).J%:۲jB@ٻ.$yNJD}x&cGsjXyvQdD&Bڦ֙Ys 5qǴ$>3?Dj6 uwQEٍK!W0+jUXH-(G/&*o[TWy֛e18#J~-_,uZՕ8J1/Rm 6,`£mt÷;8w&Q8i^MM^iV2ۑ(zĽL@}q qo-JL0S30r˦02GdFh|K]+@8d?_ZFuS}2Ln<:]F/Q0ˠ.JQhW?1gLblN8BBE4hߚA{۷wjH\@l4V̒7& '#}-\bd8ӧ(< ̺ܞFtK_Zt{7&8\/ 818CF;E)E_ar Н^l@EF fcoJpY $;:z>{0D@넫^RV{l3̇"3?F[µzx\9\8@..`ZE}elC[<:%q;bu?kM>F@q~2Nik622߯nXjtqmInΗd2i(%]of5lMl-'p]G?)hO*AUr$:m<0<_h{}c\pv=8xIi@ 7-6e_hǺL@l/  dzڇ&iI櫾2ͫŇ5To 2._N&g]2_ꤥ1|]_+'!OXԻC94_gp H/aS <:ԨAlM_}*ww\+7,w8d^+]ޏx?޻h"-iھ͗> ۯa<%(KhM7|'<]yaB [hfuzaf`LֱMad1x@9_p22xa-YkS7+u@HYDךYG_y8pVgQ8t&VFm:@+߯ekq 7}ofQP` H9{pf`. tRw]#/N*_;z{+07%>. W专r[X@;uDvMV4->yr~^9u ju=7 MUB~IޝQ KBr˥gi׊rH93.ٴnL'3m4{*o;1jN+g;VB4 r0I1Mny8dW=e1r\=㚈rт,BZLiI_QXju=7ҍp&оrD_%QQ_ D@j. ,U Zh橗5 r}͌q ^bKɳ'U7D+ 0! ,Ǥ,Vp @>{qZyBSw*1L&˭c/qr ihϮ`Wc6O_h^E~rN/8?p4hEQԸKEslĮzӺ7EdMh̆<^:F@ .7$vi7d  @͌hp]W'dUd"\4BpgL3,fyꫫ]'h'Od}dKcb#8݄zKv 0F㴟Y_QoNE1̶,^,@! 2̺ܞFx]SVeXQ0Khi9FqQFAp=1L E.d;%UVUTߛ)Sb?kat]~|]Ҵz[S/WԷ?텥,AU_eTeF&](4*Edx:qeܚIgpZ!b]MtU57)؝؟GYPZ E)o1ˢo cuZ}&'@HxIXYiϮ oBFy/,X``D/@g_h^EY>ݎD9194aUbT<#ui1VTM](88leT7eN}NRЉ.&lqIqPTưʺ |-:iEajgյ =zc^]ٚSԺCh 9IKcf; ' \+ZO1.\u=ãkIU]BB<7ԙkg:YRAOFznj' ,O5 8 xPRyH4h{G< ^l@ufe8H7t5MqE<j)XrOٸkg"9xkӯSq3]Oy޽#* YL+ fIכفt]?tDel7 Uhtu^#]C4f3+0kpYmf }j׵ZMQ^ -DOo+~.Il7zC} U*N#"ә/gq\Vޢ lG.kzaf`LֱMad8) 24ʳ.ON sa4"'\;eZFuS3 qb" \xoo;A+'ksjNvmCE ڧS7h6zqfs3P/n[tQ l(i9%dBGl~\9\X\Q9h#AjUYh! XWI lG;bs@ eFh|ko3j@gEh8VAWjNjXqQ΂:- .JEQMDEhE턮xziqh9 N&{<>(11SH5 g@ e>[ RL0 O! awZUQ-:<-dzѢϴ6"MNGu&Q0WTV} T<-‰pF\}j]$_Ny鯽Ko߾7#\/ ϳWdSs W̬qnN/@CdѤKZכ2_t_ U@6iijCԝiˉ9'JH9^F!*M(rN0[薛5 R2Џ/> t4za<tvBD}k$ZO1.\~}VV#gr5x8ޒ_Fh,ȖIcE,z3;ؿ(\m00rB od^l7Ym{ǮgqTH֩&a[=  qޅD<\sqdjSEyTyZmY+5NuT2-ʴ(KjSy љ۩ m$!g!_^gFh|KxzO;Jǡa] jL < iKy ${Ay@Bd${Ǟ>6]ĉ"u^ftmaiD}@N:Y,]k>L+\'@+ wl$4&(>dkm=}J .cO344-ƊYfv z]tnfgcvW4 hU֙Ys jD k ?sO?hN _({*^^,MtIgV'{GQv?iQy4e]z=}&QQi[/qg!$\Ԃ.| + 8b^E.> CV<<x:i6th 8ϧM\i[cix+/8@GSKh?@W囿hNm ͟xǯKl4V̒7[&;Z*MgL7-la&mf W,72 „@t@)Y^͛ة4uPw&~_߻ m sٮܕAL]4 NQ"ӼSgaHƱYbpYd%D,[q63ƅ+lџx6 &j\aWughh貞6)fX^n@ 7ل(w(fO6=x0$݈nv$!64p prq \7ifFh|Kxьx?h~;W4xh.>&$gFZ&*(Zwƒ'(`#N26}dN OWjQ0zQqrbDMzjQݔ9q;E iQvn7yX 1@4Eyg!:siw뾦æoEt:B76I]7 +:9Ķkx {Gl3c\5B'=@::@ݽ͠ ە֙Ys 4{_TMSwe !uܴ~Fq0EaB@YDgnxa:c'>AvF]Y15# َ\@4P:moM bd '#}-<ĝk !8F}%Uqj,oD=}J .a=wNj#I0}wC}h|ɏ'겉J@ ( Q FǤ,Vp p|9jvgzaf`LֱMadZO1.\ᙖv}.#-,: q7W0iϕ_DFyJ[ubM6j\LG/ V2L.(B<?1!4&\NcQva%Fq9UЭtX|8j:&qcf? <ϡRFuSڽbH_@יv <*CvI:Βp̽Y2Z \;Mo3뭧߿o ʖIcE,z3;ib[.al~r-r)7!'xJdS~ŧfflcT%:(*n[nzvp>\ϓ,16IkNQh*3 Fjw ) @ 2{f 8 ȥ&mߏi7\'fѬfUhPy^gFh|Kx8id@11qE } '#}-<]IF/@sq!(4!$2 „@r J%Nf8n$ X'{u0 8ϳ ׻w방ZO1.\6egl;%,:͛( Ytu`i;+G-t4ֆp@$\^\ XK:) ;$@.1(ufDK/Ʒg8Jn>Qg 'L#p '#}-i#/LQݟ~&",tkk<2i(%]of3=MxΘg<)^zfIzr}IGKGup!$>uk9>fƸpg4qOI:8O捌piƖ=1FڛY4ֻK+˻QnpqeT7%ucp̥4q! .-nN ֳlmekx(4bi@vVjv#>BeZpNjmaڄŶ/'  h9x޾k&@ eFh|Kxd6hq2H֙-xZ8$#~<]ehϽn ]wfahG?WҘ@r*rWQ4,<**N4R /4 /⢜)aO?<@֙Ys i_}xhO/=0HH_ݽwꍷ)J˖IcE,z3;x2ԟ;p\h Gedtn,^d,=0_cN-V{`=;z;ڮoo;#3L< 8}yq@^s-^XոldSN> t{Vƛp TQe5b<OotKƉ=8W%ՀL/@'O4uNJx :~3J`\Bzk"pY("+UD.YAB}3@EaB Zgf]fnύt#\[wPTHvȕ4h"lr/=" zj$">?7"- ׽#-ٞ<l(ڙ-xZ8o~@pZ-tz:5 ۍZE&42G⛢ڇ ˖IcE,z3;hbk9>fƸp ڻnMr <|4醣ej"Ɏ̞l"tVjv#J/KelaVnBqQFA@25 8K'E|-tMI- '8"gw5AN {G }86On[SwyMĴ-h 'Dd%8\/eH_@.aq-Sa>vz6տeEBM^`Γ B8y^ufe8H73z^"@Ҍ-{b7xH M+7qC <Ǥ,Vp ̗8V+oQАlG}Vfj4Yn{F戓j@7}LTpRW0i p̮=(A^-)90HH_ K74K-|EJ4ق 6Za6aIrElY vS7yH _iYF$-sQ5t5mdVh,sSrC.">Ѥۙ: >^rj 8K_3.3AmNNn^@!H0.(`.88 *" FQ1t rSxli+:[&@xyNmbyMg<7,:Ͱֽ`93ݪufDK/Ʒ'f)6:7]63 R2»}%7ȥ6)^aaօZehp# \dLxϦkZN*Q F<.- jṢ`8=b/`VOן{=|hhWFuS|7C&@v6F5$ \BcOvW̬qngco~g4mow!d@fݫ7@1$ڨ3[,[z59QG,̓:RWEY/ 25a98I& id;\;ُ/  gt=Mw֥i:;a tô:I5Cb!Gvk9>fƸp?$}% >T>@kh :"^Es!$q ApQզG8N]%^dueS#:32s{nَvMs< }a4?p'[@.ZQ;< tCLC<R(jm?qk۫F4* NQ.7D,zV,|eT5EU=0{ M"]l"Xf^v6kYCo#p}1h9~YuUZO1.\a#RXpE>Weyb;΍(8ˀ\x]u7g'E (dW !yrsz8~SZ_  0=ף # Ng% [g5kw^=ugs#n+,V^.D fz#vLBr?7Pݾez *b[\JW޶LfOhkC- Ke=-p E)N0C+VvـdaiD}Rxsՙ·Uͨ)gznGVϚ__N_X'uhf᭪96n3՗t/p.zI3GlĽk!M}Tz?k֧~vBю8(E#EQI  B.,oӾrC .+Vil굿Zgf]fnύtC@8 Ѳ?^vM..>\gJcUPM پ*GK){ڇT|hN, zH;Nnl:I`Ab38|٫gZnӵ^N(-M\eof \\gXZ>*Q pNF9'&z٨kYJqϵYƙ7/H ְ4Og@>vڧO/ ʌhlOL׌֙·Uͨ)gDžg4gQߡ)LiVv4vr71FEB @W̬qng(Z/'N&7ƔE@o~ۯ{ׯC pk,C/Q~ gQao[&xr$,[q63ƅ+<&"9ISPF]p&qΌhGw5.v: R2²P G^WV벉>WvC~%ur3wfI+8 ;i0-3 ӳa#u2 kؓrylԵ,{Z%8en/̛qnEr ZcJϱ46|̷6$ӧ"p|I_@2̺ܞFxV@H!$LêvfTTp m!u`5UX@p\Vo{ˍcuda>8 B5(ԽvkV4t#:3רհ-Y-hln^E\ш),:͛syhקc(-cz2,ye<6!Cl4V̒7ap禮 +K/kݞs ?smD.>{jbڥvJ~]yFy- '#}-<ЮUfƸpɤx+:[&YaD FQ;iYuӼ 8ˀrܻ{*&Ҙr/`(ʯ78dn GբՁI_a=әQId;,| ώ;Z=];#i TgXr_H&Mvʽl^R paw~&F9ܻ4W̬qnv5E5ʖ[h^nTyB@2&\a 61g">d8zgZ([&}0HH_ յ_NiȶS228j.@۷ͷ?tr깆s2FHP-K-M^j=VbQ_55ҳ鹦iNyJM8*8:Rˠ^LKE|x(n.SW_'O+@!:9?4MMl-'\KZ:#+٬ѻFhrZFED ڇ0 {F}^hw\8sٙQ/(^|hr# '#}KWm ޤ VUM@Y(>A);Zh;7F8.4 ٽf (feBi#|@ eiƇ. ={<a8iO?h1#yK[}<"pz̲ɲ_6e/qE@l4V̒7a:"QB<(#ߟ/8opt-yXubkq=ӷ;5?ڸ뾓K{Zt>7!R\aP a?&e ӈX@ F,[$@  *1L&˭c/֙Ys sIliL qJs4oo$5oy6@׿>Io 6ާg=@+oշ8RM u^L7y1K&A\~(ja:y,fộXBc γSԪꔩ5BҴ:iڇedy3mƪ`W w5`_ s8 YM@SS٨6:\V_Wi#iV (ETuшC8y:ZVN ']dZ1JDԟ0M TOʌhևOaS<_ps^XՍSH~.H& !䊦UuhFgπds:2 gwspH|.uF<h6ϻkfL;EQbM'=VVo$ѽ3J@IBӴrC.4(v37+ܷxG@ l4V̒7y=ך^ OGTucZv'Nv$&Ed/tM  ;@ Z6ׇ0^ruA PPF(w:@Z\@_Ko\ :0>J<]+[;u"$>'x>횷@ƶ<"E+UږrE*!g]A N.܀|mm^Mƙ!GNG~ 8!!.6ANurv}=t6^ԚLVQݰ bywos㚰rjaś?͏_3hRu]VEw>m>1\[q63ƅ_S @ QY M>y:ZVN8gҘH_/&jՄ4!-Q83u&ڙNc{rLH\֓'Z_Ic#~mZ[{J* ٻwf7-e-SKpQݟh'kUs] nv$dAo\eNUN&Gp/bOC6*KmKuW }vUlbr=u(ev#%!gɌh=SgruMcv tz @dQI6.>Qi48w8*6t٣ae&M-CL}|KvP}5zok2{aU] @ܯ*}[YԄ\:@2w&<r+N'_w|paID:je-ҩdk&,r*׋̧.^acAZ8ih{CiLtYFp4q/[ׄUjz5`\- YW# >uk9>fƸpob@|k^3MMdFh|K WV4e7O{l4V̒7[rz4!wztp:CYXya7͌GD}H6.TTzFH^h+^"UIjJ;qz"/ŦG.k@ L# XQh[}NWV 6?}8~~_b ))synh?HF5? zGl3c\ulMtglvyE\ػwldq:X`@>&ﺆ^'vM@ rbOFMQײi;VfתZgf]fnύt#z{srftzI}eϴ?OpQyϻ0 <7zC} %~Lb g̗8V+oQhꎀ\oMv:838 tL @7uOαSeWԸEEzz(Oj|љDkS'?KӔ 3*p,UtJ7&@6W\891E vg8dDL+ fIכفp=,rگ (ұ9S3 YM] B*e *8q&k'}O#g)FNcnr f-6e ̺ܞF]/p UUl(iL}ĕK-hJ ̽ 2ܐ-tu&ҧ,Gɓ~_'Eꭼk_7~~g.ŪŤbڈ{@6VUTDԙD5Sr\s- Mq-t@*2.1YLF7 L'N3JlM].j%p¢6ݵ@63y>o3tۛ8T\zD+ F>@dˤ`tFpijM6h8V}P:̬b; BC2=Pde'ieiLquwW̬qn>\{Ozh%t_]3}ȁ(pk9>fƸpEp6_h0 vB x;&@;Z}5h5NSX!NX9uv8yxizw R04F"3?F[gFHru1r~0Wo퇯4g ! :LeXiD,}:,[.E9^|ma4"?7)TP@k}\)7A$?MHXYi0YM9HE(879սl4V̒7Z= <>(^}{k1"թnc}֌C@}-4mG`FwmY(B*(y2"=U*V8 'Ԭ{NӺ?aն׭a:[yLɼv,Ž]*@'O8d?&NvNw+3?F[`$ Y.pTCRӱ'OOs,"ZΝ8wgӪjoo^O;vtv\KN1y>M3@?h>a=~&0\_4 $HLEt;<0\Vpq''Pk{MW-׻TєZm6q^$˸Ynf%tIQg\J<=uQqtiH)1jr2T{$F3ICer B4 ?Ƨ&m-'Y6ӂ4=c3+ eZNs4-Ti m8G'vm[[uD.@11K?U;u:PgXvr] Sr ZhxYvYv^vjVk5|ujkX5euێ1odHv ɝdW 'ʌag`*QM߶s;,Vqt2'=+3zCjnj6e8['tnz>:[&@,WC/dh{,O; < !y^2G 8 *Zꮫ9wg#*7w״&YjLG_ULo*Z䮞ΣQ2*_trkU ^C -:ۯt1ߢW$ ԟdž ֡ZJ3Y ڣ@dcZhwjQk_´0 O! )Tà#~Lb ̗8V+oQppa;BβJL0S30r˦024egH6::'g>[7x(y_h^EN,(y)n4v6%/ ֻ' |to6=BM 1z0fS؞rtQ!zg}ƚ̓fds=h'Gd4265M@A}>*]rKcI>H/./ }h˪L O :DPD2" =k z쎬ˆrӦjAԾݾ" JoIfr) `p@ (Hm pfdXuПCs;#=!bp09G @ȇč? }9a7st pS:h*M @0j+h!ĺ$yzv\?I6Rx[gx(M%J\'j4`a=]Wnz+ |q{(rjqc#g:觟yFӈ5|.֙Q9qndv?7vZMGzb:'rbMF&rl5]&'e8epnOvC#53smޠGpcOY]kT]<MxM7zhR 2KKM_~˷PЬH@ls~m嶡i3,Vq8mkm g+⢌0`Id@+`Zh2:o QM%̊JHt^h=_,^ t Ampb=#XWϯc8~r Z벌JLS|EN0>ݿ NX7ZI9pfq!T_($ *1H@&ֶ3[>IJ xd) QQU9 =ݩ^nj¦hȚ.(73{kz(.,4s6~a[zYPky\|[SN"p{|(Y33Gv:M _6#d0>ѿ':N{  %Mb ϛY/W+wQ(8Ubh>Mm5ugQ㦻/Mٳ,~ASZq8>[t+@Wɯa4"'XJιIގyH7,isKGY?D0ڨ AV %bidΌωt#{(TFU]7ToB㕿xk㍿-r)+ "E|cȖ>[J`R?wx2MK!iyҒ:ܮuHVh8Ҩj~sb ,>tsUTƚOK"@AOFZ\U-/_6` vϧ`_=EHg tY< , {ִmmqȞkP,!)$YG*ċg_UufTexNڢ d ;8̈n8ln- -벌JHoOKFrauEVN OXv BZ:'hEȚ6` d1>9j@?Hy48Q$9@Ubh>Mm5ug|xc)@QU9`=6H@K<u{VN" BeHw=z+@;<E`;sUTƚ0 t{|rr6s53sm京V,%4%1ςm㩺Lm@K&yzZgr&.}o#2@KP?D {NFI7vHK6-i+gάx ƙtR?6ALUr"pڠ:8hZe>tA9 mM&Ly~6ԯ64q*8b@?LY/Tm|M@#k0d^̗ \ d,o!^X\) t2ijL-Z{N@=&(%;w}N-ǣdzjSz2т 62<hΟt|&]="0=15g&&@#+t9slnf^Wq @, @-ncK:v$ ܝl38e$% T$7iVNN蠻^OoB3J\g1ENdeT@O Z-6kڌY3+=ޥd'bs5m[l3}\8ie`גlY\+螪#6hǍ@'V{@^Uną{Rw@<ZjtaCE{)tPv;^j-+7LdT6>@ecZ(Oh|_3*3s Ȧi+ה^,(`#_g߿b'tcc_ye{vӏa8aToN(m^J4t|qpⅻyQ*D4(d8b^E.gMRQ0KTwf9 }cR98/ 2pn #5}4[jBl9ӣMw_z훲S@mM&LSSFU]|@3:_ZZOK(bd@!Ī: L1qH ԟ칞"u3/ƫ80Qo(jp$":nTU={N)@=yB @+4UՔ#c@;C2 }YLR]Z1T2 YӞ*袋ge"sl5]NXyG_g~ N._p{ =s@48_l <ˉ55jtL-fT':Yi&Zzp(tOIQCw2y>|Ǝo#kMk/b v?K|͗yboҔWg*Lmz5luR  zye{/~ogִmmqs}KI(<G(W^o_}ӷ?V@ZmhZ U\5{7Ea"ɔo,7{#}Z A@~0F-4atg:32s<'ҍ욪"qnziL{㷀ٻHaWi^GLDof2 E2ίkj^ ='#”G@K6@KtC'MhS(@Ubh>Mm5ug|zLUO0k( QpPbF45Uus#k0D. 88.#e>K;4m[7bZӜ6js{pS~7l4mM&L"?Qz8gÒޭxL7}oVAzԏsM{_Q`7[S5Z t?K>^ťٺqe;t|qLg%t!8Ubh>Mm5ug9usk2R|v@Cƹ:n@4p}ĵz*bM/v;[O#?mj3 :\ڋraka_y7h=4Us7]$k~g؎s=-Jtx]X"ą9@4 Cয়ufTexN3 E>, *%t@4@w'jMӅ=  H] v6<+ B6 {벌RBݎ/۴%'ntד'x}wV 'zxjnu6KlΓ']] 6JMcBZ?+)aꪢ(]*SL^vItk bEeDt<4FiuE7 '#mpрh Ov /P.PD>W6Ɵ_ɶrh6t4^åJH9>@y" 9,eGQpfidy0>ӏL}܏N^n@<' 0*$z)ʏ2/,ڹ=.`:ʍ'/(&,AU^^Fq&\ũe@t*~wo~܊⺮/| Rtχs\tWaF0t1Y##T2Ӟ2 ~ y/2rb4]pԏ2ۈE+Com⭧MՑ65Z\ :*7XћWX[[wj |p龘cX^Sݿ:j.|/ZziM0]KߨEHOվ?ѐ䫻ki_ᄆOeOzp?xvo&W{:G\%Ne$s5))mӆϥ8 pIh(6Gn|)! *L$mR`ϛY/W+wQ(Z%VӤVSzfYf՝Y\'"`_h^EN,pVw4A@v_|u+1/[7iXuFV8]]e?.07o i^M: iU(-*JhiL K8Xykڶ6fpw{Bh̥8.#βO4FQx|g2~u{DWmE~/~#=#BXa={s~EHxCgyiQ =߿￿9)&n@Z^)=3a@MU$^" :TY ڹU0@? L7}o}'yGg+%◻$4~)58sviQ@!˕VkZ~2^F⽫)ZgFUfAٟ@stHdumFOյt4 ~ X1dC3! ±puƉUgXmR3ŅWM@twy_-&>=Wյpf|H~蠻ߖQ*pIP{ëL g ODXuRms*@,MGAqݗ^nu\Kǃs1Hq0]F|@6G[k7DLt=KuG;%R sga4/BEZGQeLs?84{|ay3g}k4ܠQ~4_;"^ p;cZ`O  S4{ħpUM-%XTx/O͵t^q STF3{Ė, t@<ĝ ȇBAYf՝YTO^y]C_Me#u5m[l3}\8v\yg UmR`8h?ofq\EHw*1H@&ֶ3[>n6ucɯa4"'"XU 6z;`@< qZy4J=jrz@^UnETBZ=В|14F EQ^Dk+ Mka!$5ܟxf{CǬj6&﯒Sӎzelpd g"|@,Όωt#{[] 0HɰBi Fk"'1FyPd嚰bAOFZnEGaYr P=bՏXO-s@ʙxS? Uj/L? 3Bsx:\ڋraka_y7:A뮥M]$k空冦%3뗦"NW[.D;o m~tC(&fMAx@+.7γ]~@?uRymmf֬ԣžtjg0-K./R벌YB#ge64wS!=I~xVkSNvC `N,H HcbZOI?,/ :~lhvw] 1ښM>.!~_<3xɆYS(A@7Sņ "822g. wKb+5ImF,Qݙ]tXvyc<l3f -=6pEdeM_'!(Ubh>Mm5ug|!il>*(7 2X&F9];A꧶a{E= i;>'@/% ד'[-ג G@;[Ӷ6Dž#;(ŀ88.#Z9=ۚrC9ڃk $ xrtGsyɁZ@44ۀpbQW̨8H73 "~6݂C ;LgIGC3VM? r4I)$?7@ ._@n4IJ*p^闓(!a@⃫ZG×"NW["X!犑GIK5//i-g^QM6̚GlhiL Q\GqYhbmajqQl6}pՒAwf1kF`/|7K)\QUM! =%$  #Mb ϛY/W+wQ(ҝJ 0R#ЧI.̖:32s<'ҍ\>zZY:Z(:UZr <ԝ,I+R}tվ^f;V@cp׫ aD?ӘH|14Fr$DugV ki(Bʨ˜[TG1@4yb,EhʆriaНHG j_3*3s Țj?ik1=VITqOfQ$$! ˦]_y_eT}ͫՏ?9kk;?yn9Ί|@4yU~U2Jqݗ^~GUXϞ|5m[l3}\8?OP8m(@=yB .74j77q΋8Ӣ$=B3^+,d7q!+7=z 7~"u|LsƥHdݵ2@_8/|Yek9&EO=h'RWb P ֐1 g2_3*3s w$UENc4-2ʵt0LEa tQ]:B#[j9'$E9 S33:fTS}5cCA q߄E; \8̼R7ۆ`bt{<[O:}2)%]=AD;8 Y<hJwi!H6A3 ԟ53)-xemH!@;ڼߍʸI'lsۚM>.Y;U婺phJ]za(rR".rM^˜T@49].Jo^~{$DugV 8`>&3 /@}_QR=q>1 XZ(Oh|9ӣMw_z}~Kf ~^2Wo|Ao~myyXoa%6ά_h&rLZ1)@qK8$Hwʜd8݁7Yexb?RUz/x77D4lU~1"o&<Tޔg%!XGaZaFOfk[M]-AOFz!>hikڶ6fpy(7RUuHb_&4W˯oʖIYf՝Y~Gq0H=<[; MbAwԎ >}4YtoRM}=\ug,2=jt׾XT{&^̗ \ d,h@әdͩ @Zga6UQ'frUmi<2_butҌ- ׶ǷkG{hzD+2/hENJntU:N #쏄"T(@QU9<e:UGk}:& ta$cZ'=w+ճg+7= g="~r1Hq0]F༞tA97q PR83N1zD ԟRյ=UPbnp (Xq0]FiCpV3{*-H"u5,0U0lXY4@0J ]כBݑa-JC՟X6Mp8ZEi,=lT;bsX @@(Y@,|1l__V |^7\U@(2W@\k5f'E Y8Ie:-P|EX2=jt׾){4IJ$'6@LvJ@?+)8gIqUZCǝӅ%+=@gYbZ/ |14Fr$DugV ki(.z=O.jkqT/++ʉcQCw# /^ut3'Xر_dL~-vt@ 3a1 'k K<i/p^d*^{>ۆ5ΰXU!)s♙ ^>ڻMxM7zȄ^D [ 62;gv2K>|Ia5Օ랤0KC[/qgƸhvU~1"?!]}./YCq |_&ql$zV5#Bhޏ8ͣQ㦻/MtE@o?|o?}Bz/~CdI٘.=&&td0袇7tUIqtִmmqd_6o$W/(&ҼNekc]eŪ J[`䀿ZgFUfA{ϗ)m10Mu)ZN~@%: }ӓ4xXZFbe#tQOw32 „@V䇓 V$=$onPm9t:-#iYA7ZJ^o?#1K]dECGr7V pS4Ɖ1.%TVOWK>|/=ӣMw_zW'Q<~" cf՝Y~)X B<WiS1MErU?zB^-]^2Ҙ@ npi@"Ͷ(QBx 8pn2 &YvOp 1+hE*.sjE^b yiVmkm GTOU@}(VhVW4UOx4 Se%f~%pnzI32hPd4,Fdm4AV`QIzx 2Ջ(Gv GxtGYA :>,mL}mi(V@'8̓tC @+D+< Q檙e#>R=KB0„@VIY4"՟78^VP;iZaFOfk[M]-\Nk2_ߛ5W,:ލ}>0 @ q^Ι8,WDe  ~TL?4& =(<n 5 Ea;X < mCgXq t@*s♙ ^>̍S?wx2Mx iyҒ:ܮu?_ ^Då/vڹ&X~/~#=#>=Yf՝Yz:sdu=U Ӏh,@;jU9f?Rnz-uS k@Gz&\jӒ &kiĿ'st*} ]L- @ T`)K;vr7?|7mM&=?5VbzI0h算ƒ|pf)AbHaWi^G6qcfen4}zn:32s<'ҍzvٿAڐO@Ӕ߲g8@ODZeDt#uܪ,&(%;}s9_Ƹ_188BfrFKmqtJ%gTMS8Z vx[0Q㦻/{2S)Q\GqYhbm&pfl{iVvRܿ18^Y|/ؐW%t+@~rjNjWuR l,7_pb=#u \mCgXq y}<Wϯ z}A͍>2 „@VdƷ`)q2Kmkt\~]^܆AOFZ4Rϩ"E^yK pn7iVN'&fzԸK}svXXI@ǵ'ON.ԕߺ:32s<'~OVb@^e󺣇CW&Ia3 :wNs-B7cD{0>@7?OͰ Mch#F+ %! i &@WP퓑z"r8ZB3k돽.pVdXdX~*Qu# ,k+ Mkah.sx8IK95g&l8+J7`k g:ll>Ӎ Jz$wH61P̘/}MFzAlM&LGܠlITnz^\Q&DK>., }9/uPčM׮;MXo3=jt׾߂t$'N&ϟK{-Ƒ],r)+d\Ch*/h̉Ԭ$Z8?BSMD ԟzRpfahO]Oٟpf.&(ۆ.ݿ@{rt^8P ]A]s{MI7iIo4ͣRͧi5(*٣8[Όωt/x;+Su}2>r;g[ ϥ5N }9 ^ @Pq0]F7=@wpmMs+5rH"x-׈̱ko8\ &hKBZQb3h9. \㱱tx{ q4ʴ ȥ?<xD:32s<'~lȇW= yDʚ6` y_B]t! =I! .[8.n8 ?B :t5 pfeTenXBuA ;Uw We -cjKp@ Y37J~ &t|A)t]w֙Q9qnrNM#h%%$ S3=jt׾)(SvzR;[O#?mjb8c:\ڋraka_y73>KahGjrӣ]:vM*y|Qw@8N @1?U9oeWqE-(QALmkm Gg_ ԟn_cؖ5pj$#~^ZQlԁn?~ϧK|p5ݬ(*-mA#@[w=v5i2LQ=F~RBkR$W?MŪFf4f>#YwO+ 0! mR`8tOxZf1#X #5}4[jBl9kڌY3+؟quT1 }'@~w @,ڻO:}]gy& ^fzȮHBVzZsUnƒ|14F@22`QZVn8bWCHxܟxf{CǬj6&s,tRyy06(I5~_Ϥ>q~l ę (dq]5m[l3}\8MU1F(;ʑ\&zP=TiMb;( yQ_5K-?/M\]<& ]O?i*M׋GBZMyj q~XeW2nO7"LWt+@3W ZziL$9횾/}MtGVFj4iԅARf7@ezԸK}sl( x 8@s #-SG h*gnM,VQ&2螫W|^̗ \ d,o!65Яjʱt@4|j*~^4PqR2JtQNNhz< pfYf՝Y¥aR?ό2na gW& /ÇrӓffJ=Z D;Zs#AZuYFy_)џԷMGH+qǴ:b0xuaNxtsuV _jP :GnR|J SFYuޗ w)A>=22'=UYG@B$h8vW8\aZzw/ǯs:) |Q㦻/Tש"?Zz̓2RzZgi(M`bXI #5}4[jB"ijDU3'ޝ)Ab4]hxmxVm$*'( y;n,3]&pٳۚ"b*r?6ALU8Q*|Le, ԰Vr=<;!@|l񏚲??fe_((H]Cb-VFrVG5v?+`#_g߿vz~+|MB?Wr<"*I>0 iR'r hGa_- |qt:aL`w(>rWQ*-r9 R2ֲ9DSI$)xVFj4iԅִmmqȦQFD;x*5冨bQU9qt@3Қt @!8/Όωt#ۆ1@ K,Ua]cᾔTp^O:_/ɚ6` dG7v.m(}OSmM^=b%/:filugb6ؼq"tQ?LgIGC3VDR XG7ͦ"}O z0hfe_(Vnid4Ԇ$էDn#hG~8K}0;b}IKepf_@DKM3aHψ idtҁYZ>wbiڡ>-Xye%"vktt44hEDg@yfp FMOJcB%_r8ZB3kSC]3/5z0EPQ;FQUepp}$u{"U@,mR`8tOxZB!XwkZaFOfk[M]-gzԸK}S6MM>|:@n6e6zP p _nיִқ|+_Wx߲MhO~y@_~;|@;L7y=/{ql⥛2w+wd-ʑJ׻=.[1˨*E0`]l[5eUNjSZp++((Nh$gMRQ0KTwfYpҺ44Ͱykڶ6fpdM}$_C[/qgƸ46t;*xw?ikuZTnpv@1;@s tVFbgU3|sbo?|o?}#zAo^| yF{osQ]f-QT0RS]tr}x2c1 Z麱b48@ Όωt/Z n訔 t|q5m[l3}\8"1ĺ=F,4WM?_7q΋8ӢDk.WZ YjxnBV@4h=t|qfY|XQ?JO5MR!s )W0HɰBÁ 18V5UM ̇<(GrM{/:NچHeTeN|+FO>38\v|g]`A?i}Vf@mw@K:OoQut0P鸣V>rQzx$c xJ{s6@'ǰ`1,:_ *=nWaL)hd .@W<gu{\MeUT*:XIfcMYo qAG!=3BZ9=ak3B=U~l ę ($lA*|5h' ԰Vr=<;f <襵a+{\鏼5|,y u = XQ[rde4e|w_]K~o~m?WQBzaӟX6Mp8>髐@)7=)%`N t_N󊣒`y+Ms4!@%Q?Y%VӤVSzf,m6tчGYHeTeN`+8bs>WLe@H:USmC./?c}&&F9];,Gakڶ6fpd0wˬIj3 fά@4R~XeK@8bsP4A/n*. Us{xjU9FA%`_ʻ"Iۍpwz%E"G*WDx._J/h:\p:?ZC݊4'ó*F<#:4PqR2@g79voˑZf5/zB(&fMA8ފgm_WziL,Q\GqYhbmj&WY:/sJx{̉ VLM*tO$@+aP$Mb 8rr"@Ubh>Mm5ugûm]&Ng7v8o'l,o10՟tüόQe?פ'' :UZGϣW\Ịs&0Fβ䎯eGLzϟKy-T|4U:M((2Z&*{{RUn (#_3*3s Țf ›>GE.`8hZe>tA9ȀOVn8bW# rܟxf{CǬj6&+7[0Ƶ=T'n:)ŴP 땫^IIxR.|ε0I˯߼~L7}oʮǽpi)ne5ImF,QݙȚYMO0HɰB38yh6vr 3w&yzZ~(_5K-?/M\ Ҙbc@t:ٱ?@?JixOmqhw*1H@&ֶ3[><{:t@}d* yd:zUUt5eI?rؕl; ^_^KۮV[A? Z4M6hVe{I蠫WWC-Wnz'uo} [ pU% +WS0HH[V\  S[rJ\>Z86k=Ǥ"@$8ͣ5m[l3}\8RD@o?|o?}Bz/~Cd{:W5MZ(}E#Ʈm+a3HwTIgV'n"4d]ti(V@t@,YϛY/W+wQHS\S*ϔ@;M`8Z{?P8gW맟h wXOYD J:jVW:LL/xFӂ HށGaM/e+ :H>'ֶas}AO ԟiyf돦iݦ=@:8y x 8|5z8zRБ 4,`G<t}o0@? ֭ZgFUfAt$̳|U6(z5e H"XS@; xd&;zw2@ɷ5nkߔ5ݷV~vkڶ6fpdWA_#@,Y]T]wZ3|x꩹Y $!:n_r<冲 i,ǃmWUXCgAwT0m͍te _(gF=/ x:"=.MFZ>ê.fwid冸@E^yHvH`Zh@,:% '#m-kjOa'ۭid‘]ާj`܈Z=oɴk\WkͱkUQv2 `5nkߔ5*E$UЊ%*7gG+<'dPso}e1y>ы㫗o_螟|ǿW4+n~tדkhb*|,cc$dXE!!y&]=EÔtp {eVę;/\Ora'H{m$DugV {5ge%_p! =O! )ܽ tOTaB{IY4f] lX%EN\{`sϲ<N7MVFj4iԅAÿ4@,;oz=UGS ZѼJX@30Zwߓ:)@7-yxSo- Ua"+^oU%%d|a+ZgFUfA R ĿKHeTeν3"_8ͣ|Z. %@4uW͵jk؄g@ 5.@wWs?֕ hTO|Pbgqhˏ(0HH[ˎ+2) SInpC4 Z<E5羷'=aP$Mb /,(s#X #5}4[jBl9ӣMw_zH[>|r>[lijF*-r"Ö6tLtӆC6y@kYYpRrd){V\@xiIj3 fά`?Qoz~TǪT[-^Ol=*Ft?u q&* t@:X8hZe>tA9h3ƮMMƱ? ZH'g*hۃ2"?H6 R2{G?hKB%j>l@r,DoGxiSuMMdG` ^̗ \ d,o!:=yufTexNY< 9E֞k8Z-i!SH [ WD vU~1"N3M vy$ ~qVOԙc+*h珄"׋#7q΋8Ӣ$XLF[GylVb\č:r7^o駟q{r0:[]k|:/ &?6It*1H@&ֶ3g̵l)-eMRQ0KTwferCX{~Npʑ?0?7 qc_ho@ԯ64q*bq33:fTS}5Yٽ3gnX͉Aޗ1ſn8ۃ0M=4+ ~ uT@ZسV(kf(N硻uy'XaP a&e ӈX@,(t'C+ilm = 5Oc.t>鱛~7M~y9>t{S2pfdXEq@kMm\Upm-+,zRKE\F46b:r; ZUu3*7*ziX(I2-ʴ|:ٳ\j(A% pk{jO=,֦/4OW{BZIcbp^# E>((җ jSנ:bZȚ6` dʵtT@| '#mOZ|F}b"u #@^SCm2?keW. y~h1-1m6gVup -@K2 n෺ 8.#B s;o: 7pf=u-E9k9Znz=Gc7N9'WGIVזT]Zv\ 6y4qLLYznQ6Áf8?~_f;_L_n2axHoKM{z"VI:erth`YR:KI%Xb-C?G~8\ }D(*0HH[L\e?ؚM>.IshVܞ v{\k^F*6?FaQ/ Y= H4/J=V6³9H<Ԟ+{:YM#gzԸK}s_ҔkbZT6.Olj-0 3Bspݳ]E !nGH|puy:@4-rUr?2}]WI ;-kڌY3+-Q~]t`P3{8Yz*Iq:,ERR thЏN *5cpwߓ(E?iiCQM60ZiEZ'm&oM&L/z޿8wy(;ɐeѤ_^JiFI14eM$蠓&罛a/ϬY?֣Mw_zڬ:>I!׳a寚m,<;& /v9gA]@wG5|SCduOյ+7:lSCcp[D'=aP$Mb ԟ78^VP;iZaFOfk[M]G&Gg;h"5t"5sW0Wi :n o갤[ph677sU Qp:5TwYˌW *bc ݱ ʍt_qhq"_M? r_RU:֋/qӓrZv4 t*~wo֙Q9qnmSOEHbzz!\^ƒ|ɦHݥ~˰L՗/g밇P_Swpn\,mR`8 Sſ&ÙZSk|B>`B Zќxbqx?kXfcK{lSg.&.ur.`4Ks-'O}\_lM_O !W̨8H7?` }5 VAeTe~ӓje6ecWfvtb5 =<Ԟ+{:YM#/uat/(\^*7M6䋓Yqf^8q#\Rid}U?{&MO8 &gzԸK}S4{`/,El]Ea _ ])̕8Æ$j)@{#@9#c,oGvp,3J2=jt׾_;SO$O~acX8Ԯ].P@z < IA3-<`G*)j5A]Hjoh̎HqoGώ/ga '9'I֋ēMkp }4@ %u"hyx7-F@G6Ij3 fά`B2I蜣lSe+ >sǃ8LMDφC:ۍY,xN;MtC:d( R2@|>RO8a=Vnȸqq&g䏆(`Q0 J1yJ0 F9fy&E%F&ף` њK__!<@-?D'3(J!/3 $(_W[Z5z(j+L k Medicare shifting to reference pricing? – Healthcare Economist – Insurance Info News
Home Health Insurance Medicare shifting to reference pricing? – Healthcare Economist

Medicare shifting to reference pricing? – Healthcare Economist

0
Medicare shifting to reference pricing? – Healthcare Economist

[ad_1]

That’s the abstract takeaway I had kind reviewing the 91 web page CMS steerage on the Inflation Discount Act (IRA) most honest worth (MFP) negotiation launched about 10 days in the past. Beneath, I summarize a number of the key findings.

SELECTING DRUG FOR PRICE NEGOTIATION

Unsurprisingly, CMS is searching for the best price medicine among the many 10 to be eligible for the preliminary IRA worth negotiation. Particularly, FDA is searching for small molecule merchandise with no generics which have been in the marketplace for 7 years (to allow them to negotiate at yr 9) or biologic medicine with no biosimilars which have been in the marketplace for 11 years (to allow them to negotiation in yr 13).   The very best price medicine are people who have among the many “50 qualifying single supply medicine with the best Complete Expenditures below Half D”.  These are recognized utilizing Half D prescription drug occasion (PDE) knowledge.

There are a selection of exclusions for medicine eligible for negotiation.

  • Orphan medicine: CMS won’t exclude all orphan medicine from worth negotiation.  Many medicine have an orphan indication but additionally one other indication for a non-orphan illness.  “CMS will exclude a drug or organic product that’s designated as a drug for just one uncommon illness or situation below part 526 of the FD&C Act and that’s authorised for less than a sign (or indications) for such illness or situation”
  • Low-spending Medicare medicine. Medication the place mixed Medicare Components B and D spending are lower than $200m won’t be negotiated.  Observe that this determine just isn’t inflation listed.  If not up to date over time, this exclusion will apply to fewer and fewer medicine.
  • Plasma derived merchandise.  These embrace any product derived from human entire blood or plasma.
  • Small biotech.  CMS is asking producers to submit details about its merchandise to ensure that the drug to be thought of for the exception below the small biotech rule. To succeed in the exception, CMS requires that (i) producers gross sales (based mostly on PDE knowledge) to be <1% of whole Half D expenditures and (ii) the drug into account to be “negotiation eligible” for MFP makes up ≥80% of producer’s income from Half D expenditures. If each of those standards are met, the drug would qualify for a small biotech exception.
  • Biosimilar entry.  The producer of a biosimilar could request {that a} one yr delay (“Preliminary Delay Request”) of a biosimilar is quickly to enter.  The biosimilar producer an request a second preliminary worth applicability yr (“Further Delay Request”) as effectively.  Thus, the full potential delay is 2 years. The biosimilar producer can’t be the identical firm because the reference drug (i.e., model) producer.

DRUG NEGOTIATION PROCESS

There are a selection of things CMS can contemplate as a part of
the negotiation.  These embrace non-FAMP
worth, comparative effectiveness of the chosen drug and its therapeutic
alternate options

  • Medical advance: The extent to which the
    chosen drug represents a therapeutic advance in comparison with present therapeutic
    alternate options for the chosen drug and the prices of such present therapeutic
    alternate options;
  • Therapeutic alternate options: FDA-approved
    prescribing info for the chosen drug and its therapeutic alternate options;
  • Comparative effectiveness. This consists of the
    results of the chosen drug and its therapeutic alternate options on particular
    populations (together with people with disabilities, the aged, the
    terminally in poor health, youngsters, and different affected person populations, herein known as
    “particular populations”)
  • Unmet medical want.  The extent to which the chosen drug and the
    therapeutic alternate options to the drug deal with unmet medical wants for a
    situation for which therapy or prognosis just isn’t addressed adequately by
    obtainable remedy.

CMS explicitly states that it’ll not use QALYs as a part of
the negotiation stating that info that:

“treats extending the life of people in these
populations as of decrease worth, for instance sure makes use of of quality-adjusted
life-years (QALYs), won’t be used within the negotiation course of. In cases
the place a examine makes use of QALYs in a life-extension context however has clearly separated
this use of QALYs from different proof within the report (e.g., scientific
effectiveness, dangers, harms, and many others.) that’s related to the elements listed in
part 1194(e)(2) of the Act, CMS intends to contemplate such separate proof”

CMS is contemplating quite a lot of potential paradigms for
setting drug costs together with:

  • Half D web worth(s) and/or the ASP(s) of
    therapeutic various(s), if any, to the chosen drug,
  • Unit price of manufacturing and distribution for the
    chosen drug,
  • Ceiling worth for the chosen drug
  • A home reference worth for the chosen drug
    (e.g., the Federal Provide Schedule worth),
  • A “honest revenue” worth for the chosen drug
    based mostly on whether or not analysis and improvement prices have been recouped and margin
    on unit price of manufacturing and distribution

Nonetheless, they state that:

After contemplating these choices, CMS intends to make use of the
Half D web worth(s) (“web worth(s)”) and/or ASP(s) of therapeutic
various(s) for the chosen drug, as relevant, as the place to begin for
growing the MFP preliminary provide until this web worth or ASP is bigger than
the statutory ceiling

They proceed:

“If there may be one therapeutic various for the chosen
drug, CMS intends to make use of the web worth or ASP, as relevant, of the
therapeutic various as the place to begin to develop CMS’ preliminary provide for
the MFP whether it is decrease than the ceiling. If there are a number of therapeutic
alternate options, CMS intends to contemplate the vary of web costs and/or ASPs as
effectively because the utilization of every therapeutic various to find out the
place to begin inside that vary. If the chosen drug has no therapeutic
various, if the worth of the therapeutic alternate options recognized is above
the statutory ceiling for the MFP (described in part 60.2 of this
memorandum), or if there’s a single therapeutic various with a worth above
the statutory ceiling, then CMS intends to find out the place to begin for the
preliminary provide based mostly on the Federal Provide Schedule33 (FSS) or “Large 4
Company”34 worth (“Large 4 worth”).”

Nonetheless, this preliminary worth can be adjusted based mostly a quantity
of things.

  • Medical profit. “As soon as the place to begin for the preliminary provide has been established and proof on scientific profit has been thought of, CMS intends to regulate the place to begin for the preliminary provide based mostly on the evaluation of the scientific profit (this adjusted worth is referred to herein because the “preliminary worth”)”
  • R&D prices. “if a Major Producer has not recouped its analysis and improvement prices, CMS might contemplate adjusting the preliminary”
  • Unit costs: “CMS could contemplate adjusting the preliminary worth downward if the unit price of manufacturing and distribution is decrease than the preliminary worth, or upward if the preliminary worth is near the unit prices of manufacturing and distribution”
  • Prior federal assist. “CMS could contemplate adjusting the preliminary worth downward if funding for the invention and improvement of the drug was acquired from Federal sources”
  • Patents. “CMS intends to contemplate the size of the obtainable patents and exclusivities earlier than the chosen drug could not be single supply. For instance, if the chosen drug has patents and exclusivities that may final for quite a lot of years, CMS could contemplate adjusting the preliminary worth downward
  • Industrial costs. “If the common industrial web worth is decrease than the preliminary worth, CMS could contemplate adjusting the preliminary worth downward”

As soon as a drug has a generic competitor or biosimilar, the product is not together with within the MFP negotiation in following years.

MONOPOLY PROVISIONS

The worth reductions from the utmost honest worth fluctuate based mostly on whether or not a drug is taken into account short-term (12 years or much less), long-term (greater than 16 years) or someplace in between. That is described within the desk beneath.

RELEVANT DATES

INFORMATION CMS WILL REQUEST FROM MANUFACTURERS

Info that CMS is requesting of drug producers
below the IRA drug worth negotiation are:

  • Drug costs past that collected by Medicare

    • Non-Federal common producer (Non-FAMP)
      worth: Part 1194(c)(6) of the Act defines “common non-Federal common
      producer worth” as the common of the non-FAMP (as outlined in part
      8126(h)(5) of title 38 of the U.S. Code) for the 4 calendar quarters of the
      yr concerned.
    • Non-FAMP unit: Non-FAMP unit is the package deal unit
      as described in part 8126(h)(6) of title 38 of the U.S. Code.
  • Analysis and improvement (R&D):
    • Primary Pre-Medical Analysis Prices
    • Submit-Investigational New Drug (IND) Utility
      Prices
    • Accomplished U.S. Meals and Drug Administration
      (FDA)-Required Section IV Trials
    • Deserted and Failed Drug Prices
  • Recoupment: International, Complete Lifetime Web
    Income for the Chosen Drug.  Web
    income describes income much less reductions, chargebacks and rebates.
  • Prior federal monetary assist.  This consists of tax credit, direct monetary
    assist, grants or contracts, and some other funds supplied by the 88 federal
    authorities that assist discovery, analysis, and/or improvement associated to the
    chosen drug.
  • Patent info. All pending and
    authorised patent functions, together with expired and non-expired patents
  • Market knowledge and gross sales quantity
    • Wholesale acquisition price (WAC) unit worth
    • Common producer worth (AMP) unit
    • 340B costs. 
      These embrace 340B ceiling worth and 340B prime vendor program (PVP)
      worth
    • Different federal authorities costs.  These embrace: (i) Medicaid greatest worth, (ii) Federal
      provide schedule (FSS) worth, and (iii) Large 4 worth [i.e., price for Department
      of Veterans Affairs (VA), DoD, the Public Health Service, and the Coast Guard]
    • U.S. industrial common web unit worth (with and
      with out affected person help packages)
    • Producer common web unit worth to Half D
      Plan sponsors (with and with out affected person help packages)
    • Income.  This
      consists of gross income, web income and web income with out affected person help
      packages

CMS additionally requires producers to imagine a 8.1% price of
capital.

[ad_2]

LEAVE A REPLY

Please enter your comment!
Please enter your name here